SCHEMBL5802003

SCHEMBL5802003

O=C(NCC1COc2ccccc2O1)N1CC(OC(c2ccccc2)c2ccc(Cl)cc2Cl)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
TSHR P16473 2/20 0.48
MTNR1A P48039 1/20 0.45
HPGD P15428 2/20 0.44
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 1/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
AIMP2 Q13155 1/20 0.40
GLA P06280 1/20 0.40
ALOX12 P18054 1/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4079286 0.90 NPC1 (0.52) SMN1; SMN2NPC1RAB9ATSHRMTNR1A
SCHEMBL4079289 0.88 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ATSHRMTNR1A
SCHEMBL5799246 0.82 TSHR (0.42) SMN1; SMN2NPC1RAB9ATSHRMTNR1A
SCHEMBL5804508 0.75 GRIN2B (0.51) MEN1KMT2AMAPTCYP2C9
SCHEMBL4084840 0.72 CNR1 (0.49) HPGDALDH1A1MEN1KMT2ACYP2C19
SCHEMBL29574698 0.72 CNR1 (0.49) HPGDALDH1A1MEN1KMT2ACYP2C19
SCHEMBL4078417 0.72 CNR1 (0.57) CYP2C19
SCHEMBL4079226 0.70 CNR1 (0.47) CYP2C19
SCHEMBL4188671 0.69 FAAH (0.49) CYP2C19
SCHEMBL4182420 0.69 FAAH (0.46) CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-02-01 EP disclosed
WO-2004096763-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed